DRIO
Closed
Dariohealth Corp
0.71
+0.04 (+5.97%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.67
Day's Range: 0.67 - 0.7151
Send
sign up or login to leave a comment!
When Written:
4.12
DarioHealth Corp is a digital health company that specializes in developing and commercializing innovative solutions for chronic conditions. The company's flagship product is the Dario diabetes management platform, which combines a mobile app, a blood glucose meter, and personalized coaching to help people with diabetes manage their condition more effectively.
In addition to its diabetes management platform, DarioHealth also offers a range of other digital health solutions, including remote patient monitoring, chronic care management, and behavioral health support. The company's solutions are designed to empower patients to take control of their health, while also providing healthcare providers with real-time data and insights to improve patient outcomes.
DarioHealth was founded in 2011 and is headquartered in Caesarea, Israel, with additional offices in the United States and Europe. The company is publicly traded on the Nasdaq under the ticker symbol DRIO.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
In addition to its diabetes management platform, DarioHealth also offers a range of other digital health solutions, including remote patient monitoring, chronic care management, and behavioral health support. The company's solutions are designed to empower patients to take control of their health, while also providing healthcare providers with real-time data and insights to improve patient outcomes.
DarioHealth was founded in 2011 and is headquartered in Caesarea, Israel, with additional offices in the United States and Europe. The company is publicly traded on the Nasdaq under the ticker symbol DRIO.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








